Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice

Vaccine

Volumn 25, Issue 3, 2007, Pages 577-584

  Youm, Jung Won ^a,c   Won, Young Suk ^a   Jeon, Jae Heung ^a   Ryu, Chun Jeih ^b   Choi, Yang Kyu ^c   Kim, Hyoung Chin ^a   Kim, Byung Dong ^d   Joung, Hyouk ^a   Kim, Hyun Soon ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Sejong University   (South Korea)

^c Konkuk University   (South Korea)

^d School of Agricultural Biotechnology Center for Plant Molecular Genetics and Breeding Research   (South Korea)

Author keywords

HBV; Oral immunization; Plant derived vaccine; PreS2 + S regions

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; M PROTEIN; MEMBRANE ANTIGEN; PROTEIN ANTIBODY; RECOMBINANT VACCINE; VIRUS PROTEIN; VITRONECTIN;

ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; BINDING AFFINITY; COMPETITION; CONTROLLED STUDY; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MALE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; POTATO; PRIORITY JOURNAL; TRANSGENIC PLANT;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; PLANTS, GENETICALLY MODIFIED; SOLANUM TUBEROSUM;

EID: 33845189147     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.131     Document Type: Article

References (38)

1. Peterson D.L. The structure of hepatitis B surface antigen and its antigenic sites. BioEssays 6 (1987) 258-262
2. Belgin D., Mason H.S., Richter L., Hunter J.B., and Shuler M.L. Progress options in hepatitis B surface antigen extraction from transgenic potato. Biotechnol Prog 16 (2000) 435-441
3. Smith M.L., Richter L., Arntzen C.J., Shuler M.L., and Mason H.S. Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. Vaccine 8 21 (2003) 4011-4021
4. Gao Y., Ma Y., Li M., Chenc T., Li S.W., et al. Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg. World J Gastroenterol 9 5 (2003) 996-1002
5. Mason H.S., Lam D.M.-K., and Arntzen C.J. Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 89 24 (1992) 11745-11749
6. Thanavala Y., Yang Y.F., Lyons P., Mason H.S., and Arntzen C.J. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci USA 92 8 (1995) 3358-3361
7. Kong Q., Ritcher L., Yang Y.F., Arntzen C.J., Mason H.S., and Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA 98 20 (2001) 11539-11544
8. Heermann N., Goldmann U., Schwarts W., Seyffarth T., Baumgarten H., and Gerlich W. Large surface proteins of hepatitis B virus containing the preS sequence. J Virol 52 (1984) 396-402
9. Neurath A.R., Seto B., and Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7 3 (1989) 234-236
10. Okamoto H., Yano K., Nozaki Y., Matsui A., Miyazaki H., Yamamoto K., et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 32 3 (1992) 264-268
11. Neurath A.R., Adamowicz P., Kent S.B., Riottot M.M., Strick N., Parker K., et al. Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein. Mol Immunol 23 9 (1986) 991-997
12. Pontisso P., Petit M.A., Bankowski M.J., and Peeples M.E. Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. J Virol 63 5 (1989) 1981-1988
13. Itoh Y., Takai E., Ohnuma H., Kitajima K., Tsuda F., Machida A., et al. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 83 (1986) 9174-9178
14. Park S.S., Ryu C.J., Gripon P., Guguen-Guillouzo C., and Hong H.J. Generation and characterization of a humanized antibody with specificity for preS2 surface antigen of hepatitis B virus. Hybridoma 15 6 (1996) 435-441
15. Davis H.L., and Brazolot Millan C.L. DNA-based immunization against hepatitis B virus. Springer Semin Immunopathol 19 (1997) 195-209
16. Jilg W. Novel hepatitis B vaccines. Vaccine 16 (1998) 565-568
17. Rendi-Wagner P., Shouval D., Genton B., Lurie Y., Rumke H., Boland G., et al. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine 24 (2006) 2781-2789
18. Joung Y.H., Youm J.W., Jeon J.H., Lee B.C., Ryu C.J., Hong H.J., et al. Expression of the hepatitis B surface S and preS2 antigens in tubers of Solanum tuberosum. Plant Cell Rep 22 12 (2004) 925-930
19. Richter L.J., Thanavala Y., Arntzen C.J., and Mason H.S. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 18 (2000) 1167-1171
20. Kim H.S., Kim Y.K., Ryu S.E., and Hong H.J. Production of hepatitis B virus preS polypeptide in Escherichia coli by mutation of the 5′-end coding sequence and its purification and characterization. Gene 177 1-2 (1996) 173-177
21. Hong H.J., Kim A.K., Ryu C.J., Park S.S., Chung H.K., Kwon K.S., et al. Cloning and characterization of cDNAs coding for heavy and light chains of a monoclonal antibody specific for preS2 antigen of hepatitis B virus. Gene 121 (1992) 331-335
22. Cordell G.A. Biodiversity and drug discovery a symbiotic relationship. Phytochemistry 55 6 (2000) 463-480
23. Newman D.J., Cragg G.M., and Snader K.M. The influence of natural products upon drug discovery. Nat Prod Rep 17 3 (2000) 215-234
24. Raskin I., Ribnicky D.M., Komarnytsky S., Ilic N., Poulev A., Borisjuk N., et al. Plants and human health in the twenty-first century. TRENDS Biotechnol 20 12 (2002) 522-531
25. Ogata N., Ostberg L., Ehrlich P.H., Wong D.C., Miller R.H., and Purcell R.H. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. Proc Natl Acad USA 90 (1993) 3014-3018
26. Sandhu J.S., Krasnyanski S.F., Domier L.L., Korban S.S., Osadjan M.D., and Buetow D.E. Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgen Res 9 3 (2000) 127-135
27. Wu Y.Z., Li J.T., Mou Z.R., Fei L., Ni B., Geng M., et al. Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA. Virology 313 (2003) 337-342
28. He W., Wang F., Jiang L., Li J., Liu S., and Xiao Z. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. J Gen Virol 86 (2005) 601-610
29. Trepo C., Maynard M., and Zoulim F. Perspectives on therapy of hepatitis B. J Hepatol 39 Suppl. 1 (2003) S220-S223
30. Kura M.M., Hira S., Kohli M., Dalal P.J., Ramnani V.K., and Jagtap M.R. High occurrence of HBV among STD clinic attenders in Bombay, India. Int J STD AIDS 9 (1998) 231-233
31. Faden H., Modlin J.F., Thomas M.L., McBean A.M., Ferdon M.B., and Ogra P.L. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis 162 (1990) 1291-1297
32. McCluskie M.J., Weeratna R.D., Payette P.J., and Davis H.L. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. FEMS Immunol Med Microbiol 32 3 (2002) 179-185
33. 649-684, a mucosal subunit HIV/AIDS vaccine candidate. Vaccine (2006) available online
34. Huang Z., Santi L., LePore K., Kilbourne J., Arnzten C.J., and Mason H.S. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 24 14 (2006) 2506-2513
35. Tordjeman M., Fontan G., Rabillon V., Martin J., Trepo C., Hoffenbach A., et al. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid. J Med Virol 41 (1993) 221-229
36. Tacket C.O., Mason H.S., Losonsky G., Clements J.D., Levine M.M., and Arntzen C.J. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 4 (1998) 607-609
37. Thanavala Y., Mahoney M., Pal S., Scott A., Richter L., Natarajan N., et al. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc Natl Acad Sci USA 102 (2005) 3378-3382
38. Huang Z., Elkin G., Maloney B.J., Beuhner N., Arntzen C.J., Thanavala Y., et al. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 23 (2005) 1851-1858